On January 23, 2025, the Anti-Monopoly and Anti-Unfair Competition Commission under China’s State Council officially released the PRC Anti-Monopoly Guidelines for the Pharmaceutical Sector (“the Pharmaceutical Guidelines”). From release of the draft for public comments on August 9, 2024, to its formal issuance on January 23, 2025, it took only around six months. The Pharmaceutical
China Law Vision
Blog Authors
Latest from China Law Vision
China and the U.S. – Different Approaches to Regulating AI
By Tracey TANG
Tracey Tang and Art Dicker
Artificial intelligence has become a central pillar of China in its drive to become an advanced economy. The development of AI has enjoyed tremendous government support, benefitting from a large population and data collected in China through various digital platforms. As such, China has been at the forefront of adopting…
Sensitive Personal Information in China
By Samuel Yang, Chris Fung & Helen Zhao
Abstract
This article analyses the definition, regulatory framework, and compliance challenges surrounding Sensitive Personal Information (SPI) under China’s Personal Information Protection Law (PIPL) and related standards. For enterprises, accurately identifying SPI within their data ecosystems is critical to the PIPL compliance efforts. Organisations must continually assess risks tied to data practices, particularly amid challenges posed…
Brief Analysis on 18-article Regulation for Handling Foreign-related IP Cases
On March 13, 2025, a set of regulations on tackling foreign-related intellectual property (“IP”) cases were issued by the State Council (the “New IP Regulations”)[1]. The New IP Regulations will take effect on May 1, 2025.
The New IP Regulations include 18 articles, which clarify that relevant government departments should (i) strengthen overseas IP information…
Navigating China’s Personal Data Export Compliance: Insights from MNC’s Successful Application for Security Assessment
By Albert TSUI
China’s Personal Information Protection Law (“PIPL”), enacted in 2021, establishes a structured regulatory framework for cross-border transfers of personal information (“PI”). Depending on the volume, sensitivity and context of PI being exported, exporters may face varying levels of compliance obligations. For instance, small-scale exports of non-sensitive PI may be exempt from formal applications to the…
An Overview of ARIAS US Arbitration
As Chinese insurance companies expand their overseas operations, the frequency of insurance disputes in foreign jurisdictions has also increased. In addition to traditional litigations and institutional arbitrations, there are various alternative dispute resolution methods available for resolving international insurance disputes. One such method is arbitration under relevant rules of insurance industry association.
Recently, AnJie Broad…
Rules on Mainland Asset Disposal and The Practice of Judicial Assistance by Mainland Courts in Hong Kong Company Bankruptcy
By anshouzhi & Xiaofen Zhang
Following the liquidation order from the Hong Kong High Court on January 29, 2024, against China Evergrande Group Corporation, on September 12, 2024, China Evergrande Group filed a liquidation petition for its wholly owned subsidiary, CEG Holdings (BVI) Limited, which has been scheduled a hearing on February 17, 2025. In the liquidation process of a…
AnJie Broad Partners at ABA Asia-Pacific Forum in Singapore
From 26 to 28 February 2025, Dr Zhan Hao and Ms Song Ying, partners at AnJie Broad Law Firm, participated in the ABA Asia-Pacific Conference held in Singapore Management University.
Bringing together over 200 legal professionals from around the world, the conference served as a platform for in-depth discussions on key legal and regulatory developments…
Deep Synthesis Not Deepfake: How AI Compliance Works in China
Text：
Deep synthesis (“DS”) technology is a widely used application in the field of artificial intelligence (“AI”) and a variety of scenarios, particularly in audio and video production, media communication and information services. For instance, using AI technology to “resurrect” dead people on digital gadgets is becoming a business as shown during the Qingming Festival in 2024.[1] But whether the technology and related business…
Application of the Principle of Reasonable Expectations in Insurance Law:A Comparative Analysis of U.S. and PRC Jurisdictions
By Jia Wan & Guangrui Cheng
Introduction
The primary objective of insurance law across jurisdictions is to balance the interests of policyholders, insureds, and insurers. However, the inherent complexity and standardization of insurance contracts, often drafted unilaterally by insurers, pose challenges for policyholders who may lack the expertise to fully comprehend their terms.
Insurance contracts are typically contracts of adhesion, where…